{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:57:46Z","timestamp":1791215866928,"version":"4.1.0"},"reference-count":30,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2014.0473","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:19:26Z","timestamp":1525238366000},"source":"Crossref","is-referenced-by-count":34,"title":["The Diagnosis of and Treatment Recommendations for Anxiety Disorders"],"prefix":"10.3238","author":[{"given":"Borwin","family":"Bandelow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lichte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rudolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wiltink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred E.","family":"Beutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"key":"10.3238\/arztebl.2014.0473_ref1","doi-asserted-by":"crossref","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593\u2013602.","DOI":"10.1001\/archpsyc.62.6.593"},{"key":"10.3238\/arztebl.2014.0473_ref2","doi-asserted-by":"crossref","unstructured":"Jacobi F, Hofler M, Strehle J, Mack S, et al.: Mental disorders in the general population: Study on the health of adults in Germany and the additional module mental health (DEGS1-MH). Nervenarzt 2014; 85: 77\u201387.","DOI":"10.1007\/s00115-013-3961-y"},{"key":"10.3238\/arztebl.2014.0473_ref3","doi-asserted-by":"crossref","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8\u201319.","DOI":"10.1001\/archpsyc.1994.03950010008002"},{"key":"10.3238\/arztebl.2014.0473_ref4","doi-asserted-by":"crossref","unstructured":"Kessler RC, Demler O, Frank RG, Olfson M, et al.: Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; 352: 2515\u201323.","DOI":"10.1056\/NEJMsa043266"},{"key":"10.3238\/arztebl.2014.0473_ref5","doi-asserted-by":"crossref","unstructured":"Jacobi F, Wittchen HU, Holting C, Hofler M, et al.: Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004; 34: 597\u2013611.","DOI":"10.1017\/S0033291703001399"},{"key":"10.3238\/arztebl.2014.0473_ref6","unstructured":"Bandelow B, Wiltink J, Alpers GW, Benecke C, et al.: Deutsche S3-Leitlinie zur Behandlung von Angstst\u00f6rungen. 2014. www.awmf.org\/leitlinien.html (last accessed on 26 May 2014)."},{"key":"10.3238\/arztebl.2014.0473_ref7","unstructured":"\u00c4ZQ\/AWMF: Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI). 2008: 468\u2013519."},{"key":"10.3238\/arztebl.2014.0473_ref8","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006\u201312.","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"10.3238\/arztebl.2014.0473_ref9","unstructured":"SIGN: Scottish Intercollegiate Guidelines Network www.sign.ac.uk. 2012 (last accessed on 26 May 2014)."},{"key":"10.3238\/arztebl.2014.0473_ref10","unstructured":"DIMDI: Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10th revised edition. German Modification (ICD-10-GM) 2013."},{"key":"10.3238\/arztebl.2014.0473_ref11","unstructured":"Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J: Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002; 63: 24\u201334."},{"key":"10.3238\/arztebl.2014.0473_ref12","doi-asserted-by":"crossref","unstructured":"Wittchen HU, Jacobi F: Die Versorgungssituation psychischer St\u00f6rungen in Deutschland. Eine klinisch-epidemiologische Absch\u00e4tzung anhand des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2001; 44: 993\u20131000.","DOI":"10.1007\/s001030100269"},{"key":"10.3238\/arztebl.2014.0473_ref13","doi-asserted-by":"crossref","unstructured":"Bandelow B, Boerner RJ, Kasper S, Linden M, Wittchen HU, M\u00f6ller HJ: The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int 2013; 110: 300\u201310.","DOI":"10.3238\/arztebl.2013.0300"},{"key":"10.3238\/arztebl.2014.0473_ref14","doi-asserted-by":"crossref","unstructured":"Gloster AT, Wittchen HU, Einsle F, Lang T, et al.: Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J Consult Clin Psychol 2011; 79: 406\u201320.","DOI":"10.1037\/a0023584"},{"key":"10.3238\/arztebl.2014.0473_ref15","doi-asserted-by":"crossref","unstructured":"Oyebode F, Rastogi A, Berrisford G, Coccia F: Psychotropics in pregnancy: safety and other considerations. Pharmacol Ther 2012; 135: 71\u20137.","DOI":"10.1016\/j.pharmthera.2012.03.008"},{"key":"10.3238\/arztebl.2014.0473_ref16","unstructured":"Udechuku A, Nguyen T, Hill R, Szego K: Antidepressants in pregnancy: a systematic review. Aust N Z J Psychiatry 2010; 44: 978\u201396."},{"key":"10.3238\/arztebl.2014.0473_ref17","doi-asserted-by":"crossref","unstructured":"Tuccori M, Testi A, Antonioli L, Fornai M, et al.: Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic\/noradrenergic antidepressants during pregnancy: a review. Clin Ther 2009; 31: 1426\u201353.","DOI":"10.1016\/j.clinthera.2009.07.009"},{"key":"10.3238\/arztebl.2014.0473_ref18","doi-asserted-by":"crossref","unstructured":"Broocks A, Bandelow B, Pekrun G, George A, et al.: Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998; 155: 603\u20139.","DOI":"10.1176\/ajp.155.5.603"},{"key":"10.3238\/arztebl.2014.0473_ref19","doi-asserted-by":"crossref","unstructured":"Wedekind D, Broocks A, Weiss N, Engel K, Neubert K, Bandelow B: A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder. World J Biol Psychiatry 2010; 11: 904\u201313.","DOI":"10.3109\/15622975.2010.489620"},{"key":"10.3238\/arztebl.2014.0473_ref20","unstructured":"AKD\u00c4. Therapieempfehlungen der Arzneimittelkommission der Deutschen \u00c4rzteschaft. Empfehlungen zur Therapie von Angst- und Zwangsst\u00f6rungen. 2. Auflage, 2003."},{"key":"10.3238\/arztebl.2014.0473_ref21","doi-asserted-by":"crossref","unstructured":"Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, et al.: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005; 19: 567\u201396.","DOI":"10.1177\/0269881105059253"},{"key":"10.3238\/arztebl.2014.0473_ref22","unstructured":"Canadian Psychiatric Association. Canadian Psychiatric Association Clinical Practice Guidelines, Management of Anxiety Disorders. Canadian Journal of Psychiatry 2006; 58: 1\u201392."},{"key":"10.3238\/arztebl.2014.0473_ref23","doi-asserted-by":"crossref","unstructured":"Domschke K, Hohoff C, Jacob C, Maier W, et al.: Chromosome 4q31\u201334 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 2008; 147: 510\u20136.","DOI":"10.1002\/ajmg.b.30629"},{"key":"10.3238\/arztebl.2014.0473_ref24","unstructured":"American Psychiatric Association (APA): Practice guideline for the treatment of patients with panic disorder. 2nd ed. Washington (DC): American Psychiatric Association (APA); 2009 Jan. 90 p"},{"key":"10.3238\/arztebl.2014.0473_ref25","unstructured":"Heinrichs N, Alpers GW, Gerlach AL: Evidenzbasierte Leitlinien zur Psychotherapie der Panikst\u00f6rung mit und ohne Agoraphobie und der Agoraphobie ohne Panikst\u00f6rung im Auftrag der Fachgruppe Klinische Psychologie und Psychotherapie in der Deutschen Gesellschaft f\u00fcr Psychologie (DGP). G\u00f6ttingen: Hogrefe, 2009."},{"key":"10.3238\/arztebl.2014.0473_ref26","unstructured":"Heinrichs N, Stangier U, Gerlach A, Willutzki U, Fydrich T. Evidenzbasierte Leitlinie zur Psychotherapie der Sozialen Angstst\u00f6rung. G\u00f6ttingen: Hogrefe 2010."},{"key":"10.3238\/arztebl.2014.0473_ref27","unstructured":"NICE. National Institute for Health and Clinical Excellence (NICE). Anxiety: Management of Anxiety (Panic Disorder, with or without Agoraphobia, and Generalised Anxiety Disorder) in Adults in Primary, Secondary and Community Care. 2011."},{"key":"10.3238\/arztebl.2014.0473_ref28","doi-asserted-by":"crossref","unstructured":"Eccles M, Mason J: How to develop cost-conscious guidelines. Health Technol Assess 2001; 5: 1\u201369.","DOI":"10.3310\/hta5160"},{"key":"10.3238\/arztebl.2014.0473_ref29","unstructured":"WHO. World Health Organisation: Tenth Revision of the International Classification of Diseases, Chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation, 1991."},{"key":"10.3238\/arztebl.2014.0473_ref30","doi-asserted-by":"crossref","unstructured":"Bandelow B, Zohar J, Hollander E, et al.: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders \u2013 first revision. World J Biol Psychiatry 2008; 9: 248\u2013312.","DOI":"10.1080\/15622970802465807"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T08:40:07Z","timestamp":1638780007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,7]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2014.0473","relation":{"is-cited-by":[{"id-type":"doi","id":"10.3389\/fneur.2017.00626","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,7]]}}}